Live from the NIH registry
Studies recruiting near Baton Rouge right now
Top 25 of 218 recruiting studies, sorted by proximity — each links to its official registry page
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Mary Bird Perkins Cancer Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: NRG Oncology
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Pennington Biomedical Research Center /ID# 262390 — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: AbbVie
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50023 — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: UCB Biopharma SRL
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
Delricht Research — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Incyte Corporation
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
Normal and Diseased Tissue and Body Fluids Samples
N/A
Observational 100,000 participants sought
Our Lady of the Lake Regional Medical Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: St. Jude Children's Research Hospital
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Baton Rouge, LA Investigative Site 10030 — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Colorado Prevention Center
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 960 participants sought
GSK Investigational Site — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: GlaxoSmithKline
Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition
Alzheimer s Disease, Alzheimer Blood Biomarkers
N/A
Interventional 8 participants sought
Pennington Biomedical Research Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Pennington Biomedical Research Center
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
LSU Health Baton Rouge-North Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Urinary Bladder Neoplasms, Neoplasm Metastasis
Phase 1
Interventional 677 participants sought
Mary Bird Perkins Cancer Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Eli Lilly and Company
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: AstraZeneca
Diet-Induced Changes in GEnetic Material
Diet, Healthy, Body Weight
N/A
Observational 10 participants sought
Pennington Biomedical Research Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Pennington Biomedical Research Center
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Mary Bird Perkins Cancer Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Eli Lilly and Company
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Newly Diagnosed Multiple Myeloma
Phase 3
Interventional 750 participants sought
Research Site — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: AstraZeneca
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Medtronic
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Sickle Cell Disease
Phase 2, Phase 3
Interventional 389 participants sought
LSU Health Baton Rouge-North Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Pfizer
R61/33 - VR Study Phase 4
Attention Deficit Hyperactivity Disorder
Phase 4
Interventional 252 participants sought
Louisiana State University — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Rutgers, The State University of New Jersey
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
Gastrointestinal Neoplasms
Phase 3
Interventional 450 participants sought
GSK Investigational Site — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: GlaxoSmithKline
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Hematology/Oncology Clinic PLLC — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: SWOG Cancer Research Network
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Phase 2
Interventional 93 participants sought
LSU Health Baton Rouge-North Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Local Institution - Unk011 — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Mirati Therapeutics Inc.
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Louisiana Hematology Oncology Associates LLC — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: NRG Oncology
Pounce™ Thrombectomy System Retrospective Registry
Peripheral Arterial Disease, Acute Limb Ischemia
N/A
Observational 500 participants sought
Baton Rouge General Medical Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: SurModics, Inc.
Four Pillars of Defense: A Whole Health Approach to the Military
Health Behavior
N/A
Interventional 400 participants sought
Pennington Biomedical Research Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Pennington Biomedical Research Center
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 40 — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Merus B.V.